Abstract
Currently, the treatment options for fungal infections, such as oral candidosis, present limitations due to the low availability of antifungal drugs and the emergence of drug resistant strains. The use of probiotics is considered promising because they have antimicrobial activity as well as immunomodulatory action, but its clinical application in immunocompromised patients is critical due…